Highlighting Pediatric Preclinical Drug Testing at the Annual Meeting 2018

The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at the Annual Meeting, where ongoing advances and existing challenges in cancer research will be discussed through the pediatric lens.

Read More

Early-career Researchers Share Their Passions on Capitol Hill

US Capitol Building

Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where they meet with legislators and policymakers to discuss issues that are critical to supporting medical research.

Read More

Improving the Effectiveness of CAR T-cell Immunotherapy

A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key ingredient necessary to make effective chimeric antigen receptor (CAR) T cells – the T cells of a patient. The researchers behind this study have identified one potential reason for why we have not been successful in making CAR T-cell therapy work against solid tumors, and offer a solution.

Read More

AACR Previews Research from Annual Meeting 2018

In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is expected to draw about 22,000 attendees, including cancer researchers, clinicians, and advocates.

As always, the meeting features a wide range of high-impact science, featuring presentations on all aspects of basic and translational cancer research, including immunotherapy, precision medicine, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, cancer disparities, and survivorship.

Read More

Why We Need Tailored Tobacco-control Strategies

Cigarette smoking is linked to 18 different types of cancer. It is the leading preventable cause of cancer in the United States, accounting for 19 percent of the 1,570,978 cancers diagnosed in U.S. adults ages 30 and older in 2014, according to the latest research. Another 0.4 percent of the cancer diagnoses in the U.S. that year were attributable to exposure to secondhand smoke.

That’s why February, which is National Cancer Prevention Month, is a good time to raise awareness of the dangers of cigarette smoking and exposure to secondhand smoke.

Read More

Joint Workshop to Address Lack of Drug-Radiotherapy Combinations

The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as multiple myeloma and metastatic melanoma, are turning into chronic diseases due to the use of novel, targeted systemic therapies. Immunotherapy is altering the natural history of certain malignancies.

Read More